Icatibant is used to treat attacks of hereditary angioedema (an immune system disorder). This medication is used in people who are at least 18 years old. Icatibant is not a cure for hereditary angioedema.
Icatibant Acetate
Specifications
Human
Injectable
Commercial
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.